Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: A Retrospective observational study

BMJ Open

Volumn 5, Issue 9, 2015, Pages

  Barulli, Maria Rosaria ^a   Fontana, Andrea ^b   Panza, Francesco ^a   Copetti, Massimiliano ^b   Bruno, Stefania ^a   Tursi, Marianna ^a   Iurillo, Annalisa ^a   Tortelli, Rosanna ^a   Capozzo, Rosa ^a   Simone, Isabella Laura ^a   Logroscino, Giancarlo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; EXECUTIVE FUNCTION; FEMALE; FRONTAL ASSESSMENT BATTERY; FRONTAL LOBE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; SEMANTIC MEMORY; AGED; COMPLICATION; DEMENTIA; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84947908881     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007069     Document Type: Article

References (43)

1. Strong MJ, Grace GM, Orange JB, et al. A prospective study of cognitive impairment in ALS. Neurology 1999;53:1665-70.
2. Lomen-Hoerth C, Murphy J, Langmore S, et al. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094-7.
3. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-46.
4. Elamin M, Phukan J, Bede P, et al. Executive impairment is a negative prognostic indicator in ALS patients without dementia. Neurology 2011;76:1263-9.
5. Gordon PH, Wang Y, Doorish C, et al. A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler 2007;8:362-5.
6. Dubois B, Slachevsky A, Litvan I, et al. The FAB: Frontal Assessment Battery at bedside. Neurology 2000;55:1621-6.
7. Apollonio I, Leone M, Isella V, et al. The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 2005;26:108-16.
8. Folstein MF, Folstein SE, McHugh P. 'Mini-mental state': a practical method for grading the cognition of patients for the clinician. J Psychiatric Res 1975;12:189-98.
9. Oskarsson B, Quan D, Rollins YD, et al. Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: a preliminary experience. Amyotroph Lateral Scler 2010;11:244-7.
10. Ahn SW, Kim SH, Kim JE, et al. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients. Can J Neurol Sci 2011;38:242-6.
11. Floris G, Borghero G, Chiò A, et al. Cognitive screening in patients with amyotrophic lateral sclerosis in early stages. Amyotroph Lateral Scler 2012;13:95-101.
12. Von Elm E, Altman DG, Egger M, et al., STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8.
13. Bossuyt PM, Reitsma JB, Bruns DE, et al., Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-12.
14. Brooks BR, World Federation of Neurology Sub-Committee on Motor Neuron Diseases. El Escorial WFN criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124:965-1085.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM IV-TR). 4th edn. Washington DC: American Psychiatric Association, 2000.
16. Magni E, Binetti G, Bianchetti A, et al. Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol 1996;3:1-5.
17. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS Functional Rating Scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169:13-21.
18. Great Lakes ALS Study Group. A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis. Neurology 2003;61:1503-7.
19. Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry 2006;77:390-2.
20. Smith A. Symbol Digit Modalities Test. Los Angeles, CA: Western Psychological Services, 1991.
21. Nocentini U, Giordano A, Di Vincenzo S, et al. The Symbol Digit Modalities Test-Oral Version: Italian normative data. Funct Neurol 2006;21:93-6.
22. Caffarra P, Vezzadini G, Dieci F, et al. Una versione abbreviata del test di Stroop: dati normativi nella popolazione Italiana. Riv Neurol 2002;12:111-15.
23. Benton AL, Hamsher K. Multilingual Aphasia Examination manual. Iowa City: University of Iowa, 1976.
24. Carlesimo GA, Caltagirone C, Gainotti G. The Mental deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of Mental Deterioration Battery. Eur Neurol 1996;36:378-84.
25. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, Texas: Psychological Corporation, 1996.
26. Muscarella LA, Barbano R, D'Angelo V, et al. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics 2011;6:317-25.
27. Hanley JA, McNeil BJ. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology 1982;143:29-36.
28. Efron B, Tibshirani R. An Introduction to the Bootstrap. Boca Raton, FL: Chapman & Hall/CRC, 1993.
29. Swets JA. Signal detection theory and ROC analysis in psychology and diagnostics: collected papers. Mahwah, NJ: Lawrence Erlbaum Associates, 1996.
30. Terada T, Obi T, Miyajima H, et al. Assessing frontal lobe function in patients with amyotrophic lateral sclerosis by frontal assessment battery. Rinsho Shinkeigaku 2010;50:379-84.
31. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102-8.
32. Atassi N, Cook A, Pineda CM, et al. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:109-12.
33. Kurt A, Nijboer F, Matuz T, et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 2007;21:279-91.
34. Wicks P, Abrahams S, Masi D, et al. Prevalence of depression in a 12-month consecutive sample of patients with ALS. Eur J Neurol 2007;14:993-1001.
35. Raaphorst J, Beeldman E, Jaeger B, et al. Is the Frontal Assessment Battery reliable in ALS patients? Amyotroph Lateral Scler Frontotemporal Degener 2013;14:73-4.
36. Osborne RA, Sekhon R, Johnston W, et al. Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. J Neurol Sci 2014;336:191-6.
37. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002;59:1077-9.
38. Rhingholz GM, Appel SH, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586-90.
39. Lillo P, Savage S, Mioshi E, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler 2012;13:102-9.
40. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257-68.
41. De Jesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-56.
42. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012;11:232-40.
43. Abrahams S, Newton J, Niven E, et al. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:9-14.